Home / Tag Archives: Trovagene

Tag Archives: Trovagene

Stocks Buzz: Trovagene, Inc. (NASDAQ: TROV)

Trovagene, Inc. (NASDAQ: TROV), a precision medicine biotechnology company, declared recently that is has formally engaged PRA Health Sciences, a leading, global contract research organization (CRO), to conduct Trovagene’s Phase 1b/2 clinical trial of PCM-075, a polo-like kinase 1 (PLK1) inhibitor, in patients with acute myeloid leukemia (AML). Trovagene filed …

Read More »